| 921/1816 | US=28 / Urologia Aron M, Haber GP, Gill IS. Minimally invasive nephron-sparing surgery for renal tumors: laparoscopic partial nephrectomy and probe ablative treatment. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 219-46. ISBN 978-1-58829-251-3. CIRURGIA MINIMAMENTE INVASIVA NEFRON; POUPADORES PARA OS TUMORES RENAIS; NEFRECTOMIA PARCIAL LAPAROSCOPICA. TRATAMENTO SONDA ABLATIVO; NEFRECTOMIA PARCIAL LAPAROSCOPICA; CRIOABLACAO; ABLACAO POR RADIOFREQUENCIA |
| 922/1816 | US=28 / Urologia Kansas BT, Crispen PL, Uzzo RG. The role of angioinfarction in the management of renal tumors. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 247-64. ISBN 978-1-58829-251-3. PAPEL DA ANGIOMIOLIPOMA NA GESTAO DOS TUMORES RENAIS; HIPERVASCULARIZACAO; MATERIAIS DE EMBOLIZACAO; ANGIOMIOLIPOMA TERAPEUTICA PARA O CARCINOMA DE CELULAS RENAIS; EMBOLIZACAO PARA ANGIOMIOLIPOMA |
| 923/1816 | US=28 / Urologia Margulis V, Martin SF, Wood CG. Surveillance strategies following curative therapy for localized renal cell carcinoma. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 265-73. ISBN 978-1-58829-251-3. ESTRATEGIAS DE VIGILANCIA; CARCINOMA DE CELULAS RENAIS LOCALIZADO |
| 924/1816 | US=28 / Urologia McNeil BK, Campbell SC. Local recurrence of renal cell carcinoma: management. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 275-92. ISBN 978-1-58829-251-3. RECIDIVA LOCAL DO CARCINOMA DE CELULAS RENAIS; INCIDENCIA APOS CIRURGIA LAPAROSCOPICA; RECORRENCIA LOCAL APOS NEFRECTOMIA RADICAL; RECURRENTE LOCAL APOS TERMICAS TERAPIAS ABLATIVAS |
| 925/1816 | US=28 / Urologia Bukowski RM. Adjuvant therapy of renal cell carcinoma. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 293-306. ISBN 978-1-58829-251-3. TERAPIA ADJUVANTE DO CARCINOMA DE CELULAS RENAIS; CARCINOMA DE CELULAS RENAIS; VACINA TUMOR AUTOLOGO; ADJUVANTES ENSAIOS DE CITOCINAS |
| 926/1816 | US=28 / Biol/Mol Teicher BA. Newer vascular targets. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 133-53. ISBN 978-1-58829-870-6. MAIS RECENTES ALVOS VASCULARES; SAGE; ENDOSSIALINA; TEM; ANGIOGENESE ANTI; VASCULAR ALVO; GENE-EXPRESSAO ANALISE |
| 927/1816 | US=28 / Urologia Elson PJ. Prognostic factors for survival in metastatic renal cell carcinoma. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 307-22. ISBN 978-1-58829-251-3. |
| 928/1816 | US=28 / Urologia Elson PJ. Prognostic factors for survival in metastatic renal cell carcinoma. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 307-22. ISBN 978-1-58829-251-3. |
| 929/1816 | US=28 / Biol/Mol Keane MP, Belperio JA, Strieter RM. Chemokines in angiogenesis. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 155-70. ISBN 978-1-58829-870-6. QUIMIOCINAS NA ANGIOGENESE; RECEPTOR QUIMIOCINAS; ANGIOGENESE; CANCER |
| 930/1816 | US=28 / Biol/Mol Kabayashi H, DeBush LM, Lin PC. Angiopoietin/Tie2 signaling regulates tumor angiogenesis. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 171-87. ISBN 978-1-58829-870-6. ANGIOPOIETINA; AMARRAR; ANGIOGENESE TUMORAL; VEGF; CANCER; METASTASE |
| 931/1816 | US=28 / Urologia Majhail NS, Bukowski RM. Fuctional imaging of renal cell carcinoma. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 323-33. ISBN 978-1-58829-251-3. IMAGIOLOGIA FUNCIONAL DE CARCINOMA DE CELULAS RENAIS; F-18 FLUORODEOXIGLICOSE; TOMOGRAFIA POR EMISSAO DE POSITRONS |
| 932/1816 | US=28 / Biol/Mol Kalva SP, Namasivayam S, Kabayashi H, DeBush LM, Lin PC. Imaging angiogenesis. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 189-203. ISBN 978-1-58829-870-6. IMAGEM ANGIOGENESE; PERFUSAO CT; PERFUSAO MRI; COM CONTRASTE DE ULTRA-SOM; ANGIOGENESE |
| 933/1816 | US=28 / Biol/Mol Nagy JA, Fu Y, Dvorak AM, Dvorak HF. Tumor blood vessels. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 205-24. ISBN 978-1-58829-870-6. VEGF-A; VASOS SANGUINEOS TUMORAIS; ANGIOGENESE; ARTERIOGENESE; VENOGENESIS |
| 934/1816 | US=28 / Urologia Orris BG, Flanigan RC. Nephrectomy in patients with metastatic renal cell carcinoma: clinical and biologic effects. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 335-53. ISBN 978-1-58829-251-3. NEFRECTOMIA; CARCINOMA DE CELULAS RENAIS METASTATICO. PACIENTES COM NEFRECTOMIA |
| 935/1816 | US=28 / Urologia Oliver T, Powles T, Narrgund V, Berney D. Spontaneous regression of renal cell carcinoma and the role of prognostic factors. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 355-66. ISBN 978-1-58829-251-3. REGRESSAO ESPONTANEA DE CARCINOMA; CARCINOMA DE CELULAS RENAIS; PROGNOSTICOS; PARAMETROS SANGUINEOS PERIFERICOS |
| 936/1816 | US=28 / Urologia Jin JO, Stadler WM. Chemotherapy for metastatic clear-cell renal cell carcinoma. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 385-97. ISBN 978-1-58829-251-3. QUIMIOTERAPIA PARA CARCINOMA DE CELULAS RENAIS DE CELULAS CLARAS; AGENTE UNICO DE QUIMIOTERAPIA; TERAPIA HORMONAL; TERAPIA COMBINADA CHEMOHORMONAL |
| 937/1816 | US=28 / Urologia Ronnem EA, George S, Bukowski RM, Motzer RJ. Signal transduction inhibitors in renal cell carcinoma. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 399-413. ISBN 978-1-58829-251-3. INIBIDORES DE TRANSDUCAO DE SINAL EM CARCINOMA DE CELULAS RENAIS; CARCINOMA DE CELULAS RENAIS METASTATICO; PAPILAR CARCINOMA DE CELULAS RENAIS |
| 938/1816 | US=28 / Biol/Mol Pytowshi B. Lymphatic system in the pathology of cancer. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 225-41. ISBN 978-1-58829-870-6. SISTEMA LINFATICO NA PATOLOGIA DO CANCRO; CELULAS ENDOTELIAIS; LINFA; LINFONODOS; VASOS LINFATICOS; CANCER; DESENVOLVIMENTO; METASTASE |
| 939/1816 | US=28 / Biol/Mol Maharaj ASR, D'Amore PA. VEGF in the adult. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 245-59. ISBN 978-1-58829-870-6. VEGF; ANGIOGENESE; PRE-ECLAMPSIA; TERAPIA ANTI-ANGIOGENICA; BEVACIZUMAB; CELULAS ENDOTELIAIS |
| 940/1816 | US=28 / Biol/Mol Jain RK, Batchelor TT, Duda DG, Willett CG. Normalization of tumor vasculature and microenvironment. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 261-76. ISBN 978-1-58829-870-6. |